Japfa Comfeed Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Japfa Comfeed Indonesia Tbk. trades at Rp2,030 (market cap 23.8T, 8.44M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 2.1× Tempo Scan Pacific Tbk.'s market cap, and Japfa Comfeed Indonesia Tbk. is more actively traded (8.44M versus 1.77M). Which is the better fit depends on your goals.
| JPFA | TSPC | |
|---|---|---|
Market Cap | 23.8T | 11.36T |
Volume | 8.44M | 1.77M |
Lot | 84.36K | 17.71K |
Turnover | 17.08B | 4.61B |
Average Price | 2,024.41 | 2,603.9 |
Value | 17.08B | 4.61B |
Indicative Equilibrium Price | 2,030 | 2,590 |
Indicative Equilibrium Volume | 3.58K | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Read more on JPFA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →